Search

Your search keyword '"Thyroid Neoplasms blood"' showing total 95 results

Search Constraints

Start Over You searched for: Descriptor "Thyroid Neoplasms blood" Remove constraint Descriptor: "Thyroid Neoplasms blood" Publication Year Range More than 50 years ago Remove constraint Publication Year Range: More than 50 years ago
95 results on '"Thyroid Neoplasms blood"'

Search Results

1. Medullary carcinoma of the thyroid gland: use of biochemical parameters in detection and surgical management of the tumor.

4. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].

5. Calcitonin inhibition of gastrin secretion in man.

6. [Experiences with the effective Thyroxine Ratio (ETR) test].

9. Secretion of parathyroid hormone in patients with medullary thyroid carcinoma.

10. Radioimmunoassay for calcitonin in medullary thyroid carcinoma.

11. Serum calcitonin in medullary thyroid carcinoma. Radioimmunoassay technique and diagnostic value.

12. [Discrepancy between clinical status and in vitro thyroid function tests].

15. Multiple immunoreactive forms of calcitonin in human plasma.

16. Human calcitonin. Immunologic assay, cytologic localization and studies on medullary thyroid carcinoma.

17. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.

18. Diagnostic applications of calcitonin immunoassay.

19. Laboratory diagnosis of thyroid tumors.

20. Radioimmunoassay of human plasma calcitonin.

21. [Study of the plasma thyrotropin in thyroid diseases].

22. Serum lipids in human cancer.

23. [Triosorb, tetrasorb and T3 values as indicators of thyroid function].

25. Clinical applications of radioimmunoassay of plasma parathyroid hormone.

26. [Activity of human growth hormone (HGH) in serum following insulin stimulation in radioiodine treated toxic adenoma and Basedow disease].

28. Calcitonin in human serum. Detection by tissue culture bioassay in medullary carcinoma of the thyroid and other disorders.

29. [Calcitonin--interpretation of the test results].

30. Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.

31. Radiation sickness after therapeutic administration of 806 mCi of 131I for thyroid cancer.

32. [Iodine metabolism disorders in thyroid gland carcinoma].

33. [Calcium infusion test in thyroid disorders].

34. [Automated determination of hormonal iodine in the plasma: methodology, experimental study, clinical application].

35. Immuno-reactive material to bovine TSH in plasma from patients with thyroid cancer.

36. Evaluation of thyroid function.

37. Medullary thyroid carcinoma detected by serum calcitonin assay.

38. Radioiodine-labeled proteins in the serum of patients treated with 131I for thyroid disease.

39. [Radiation-induced changes in the distribution of serum protein-bound endogenous activity in patients treated with 131-I].

40. Serum phospholipids in neoplastic disorders.

42. Phenotype of malignancy: the mucosal neuroma syndrome.

43. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.

45. Immunoassay for human calcitonin. II. Clinical studies.

46. [Plasma transport of thyroid hormones in euthyroidism and toxic thyroid adenoma].

47. [Behavior of the peripheral blood picture and the plasma protein fractions after therapeutic radioisotope incorporation].

48. Calcitonin secretion in medullary carcinoma of the thyroid.

50. Plasma thyrotrophin levels in thyroid disease and effect of treatment.

Catalog

Books, media, physical & digital resources